Global Prostate Cancer Drugs Market Research Report 2018

Publisher Name :
Date: 05-Jun-2018
No. of pages: 106
Inquire Before Buying

This report studies the global Prostate Cancer Drugs market status and forecast, categorizes the global Prostate Cancer Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Prostate Cancer Drugs market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report

- AbbVie

- Astellas Pharma

- Astra Zeneca

- Johnson & Johnson

- Sanofi

- GlaxoSmithKline

- Merck Group

- Novartis

- Amgen

- Bayer HealthCare

- Ferring Pharmaceutical

- Janssen Pharmaceuticals

- Endo Pharmaceuticals

- BMS

- Takeda Pharmaceuticals

- Northwest Biotherapeutics

- Teva Pharmaceutical

- Boehringer Ingelheim

- Foresee Pharmaceuticals

- Tokai Pharmaceuticals

- Spectrum Pharmaceuticals

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Hormonal Therapy

- Chemotherapy

- Immunotherapy

- Targeted Therapy

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

- Clinics

- Hospitals

- Other

The study objectives of this report are:

- To analyze and study the global Prostate Cancer Drugs sales, value, status (2013-2017) and forecast (2018-2025).

- Focuses on the key Prostate Cancer Drugs manufacturers, to study the sales, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Prostate Cancer Drugs are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Prostate Cancer Drugs Manufacturers

Prostate Cancer Drugs Distributors/Traders/Wholesalers

Prostate Cancer Drugs Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Prostate Cancer Drugs market, by end-use.

Detailed analysis and profiles of additional market players.

Global Prostate Cancer Drugs Market Research Report 2018

Table of Contents
Global Prostate Cancer Drugs Market Research Report 2018
1 Prostate Cancer Drugs Market Overview
1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Prostate Cancer Drugs Segment by Type (Product Category)
1.2.1 Global Prostate Cancer Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Prostate Cancer Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 Hormonal Therapy
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.2.6 Targeted Therapy
1.3 Global Prostate Cancer Drugs Segment by Application
1.3.1 Prostate Cancer Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Global Prostate Cancer Drugs Market by Region (2013-2025)
1.4.1 Global Prostate Cancer Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Prostate Cancer Drugs (2013-2025)
1.5.1 Global Prostate Cancer Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Prostate Cancer Drugs Capacity, Production Status and Outlook (2013-2025)
2 Global Prostate Cancer Drugs Market Competition by Manufacturers
2.1 Global Prostate Cancer Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Prostate Cancer Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Prostate Cancer Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Prostate Cancer Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Prostate Cancer Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Prostate Cancer Drugs Market Competitive Situation and Trends
2.5.1 Prostate Cancer Drugs Market Concentration Rate
2.5.2 Prostate Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Prostate Cancer Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Prostate Cancer Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Prostate Cancer Drugs Production and Market Share by Region (2013-2018)
3.3 Global Prostate Cancer Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Prostate Cancer Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Prostate Cancer Drugs Consumption by Region (2013-2018)
4.2 North America Prostate Cancer Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Prostate Cancer Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Prostate Cancer Drugs Production, Consumption, Export, Import (2013-2018)
4.5 Japan Prostate Cancer Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Prostate Cancer Drugs Production, Consumption, Export, Import (2013-2018)
4.7 India Prostate Cancer Drugs Production, Consumption, Export, Import (2013-2018)
5 Global Prostate Cancer Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Prostate Cancer Drugs Production and Market Share by Type (2013-2018)
5.2 Global Prostate Cancer Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Prostate Cancer Drugs Price by Type (2013-2018)
5.4 Global Prostate Cancer Drugs Production Growth by Type (2013-2018)
6 Global Prostate Cancer Drugs Market Analysis by Application
6.1 Global Prostate Cancer Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Prostate Cancer Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Prostate Cancer Drugs Manufacturers Profiles/Analysis
7.1 AbbVie
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Prostate Cancer Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AbbVie Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Astellas Pharma
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Prostate Cancer Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Astellas Pharma Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Astra Zeneca
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Prostate Cancer Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Astra Zeneca Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Johnson & Johnson
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Prostate Cancer Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Johnson & Johnson Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Sanofi
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Prostate Cancer Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Sanofi Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Prostate Cancer Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 GlaxoSmithKline Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Merck Group
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Prostate Cancer Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Merck Group Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Novartis
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Prostate Cancer Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Novartis Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Amgen
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Prostate Cancer Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Amgen Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Bayer HealthCare
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Prostate Cancer Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Bayer HealthCare Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
7.10.4 Main Business/Business Overview
7.11 Ferring Pharmaceutical
7.12 Janssen Pharmaceuticals
7.13 Endo Pharmaceuticals
7.14 BMS
7.15 Takeda Pharmaceuticals
7.16 Northwest Biotherapeutics
7.17 Teva Pharmaceutical
7.18 Boehringer Ingelheim
7.19 Foresee Pharmaceuticals
7.20 Tokai Pharmaceuticals
7.21 Spectrum Pharmaceuticals
8 Prostate Cancer Drugs Manufacturing Cost Analysis
8.1 Prostate Cancer Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Prostate Cancer Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Prostate Cancer Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Prostate Cancer Drugs Market Forecast (2018-2025)
12.1 Global Prostate Cancer Drugs Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Prostate Cancer Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Prostate Cancer Drugs Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Prostate Cancer Drugs Price and Trend Forecast (2018-2025)
12.2 Global Prostate Cancer Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Prostate Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Prostate Cancer Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Prostate Cancer Drugs Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Prostate Cancer Drugs
Figure Global Prostate Cancer Drugs Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Prostate Cancer Drugs Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Hormonal Therapy
Table Major Manufacturers of Hormonal Therapy
Figure Product Picture of Chemotherapy
Table Major Manufacturers of Chemotherapy
Figure Product Picture of Immunotherapy
Table Major Manufacturers of Immunotherapy
Figure Product Picture of Targeted Therapy
Table Major Manufacturers of Targeted Therapy
Figure Global Prostate Cancer Drugs Consumption (K Pcs) by Applications (2013-2025)
Figure Global Prostate Cancer Drugs Consumption Market Share by Applications in 2017
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Prostate Cancer Drugs Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2013-2025)
Figure North America Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Prostate Cancer Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Prostate Cancer Drugs Capacity, Production (K Pcs) Status and Outlook (2013-2025)
Figure Global Prostate Cancer Drugs Major Players Product Capacity (K Pcs) (2013-2018)
Table Global Prostate Cancer Drugs Capacity (K Pcs) of Key Manufacturers (2013-2018)
Table Global Prostate Cancer Drugs Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Prostate Cancer Drugs Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Prostate Cancer Drugs Capacity (K Pcs) of Key Manufacturers in 2018
Figure Global Prostate Cancer Drugs Major Players Product Production (K Pcs) (2013-2018)
Table Global Prostate Cancer Drugs Production (K Pcs) of Key Manufacturers (2013-2018)
Table Global Prostate Cancer Drugs Production Share by Manufacturers (2013-2018)
Figure 2017 Prostate Cancer Drugs Production Share by Manufacturers
Figure 2017 Prostate Cancer Drugs Production Share by Manufacturers
Figure Global Prostate Cancer Drugs Major Players Product Revenue (Million USD) (2013-2018)
Table Global Prostate Cancer Drugs Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Prostate Cancer Drugs Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Prostate Cancer Drugs Revenue Share by Manufacturers
Table 2018 Global Prostate Cancer Drugs Revenue Share by Manufacturers
Table Global Market Prostate Cancer Drugs Average Price (USD/Pcs) of Key Manufacturers (2013-2018)
Figure Global Market Prostate Cancer Drugs Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Prostate Cancer Drugs Product Category
Figure Prostate Cancer Drugs Market Share of Top 3 Manufacturers
Figure Prostate Cancer Drugs Market Share of Top 5 Manufacturers
Table Global Prostate Cancer Drugs Capacity (K Pcs) by Region (2013-2018)
Figure Global Prostate Cancer Drugs Capacity Market Share by Region (2013-2018)
Figure Global Prostate Cancer Drugs Capacity Market Share by Region (2013-2018)
Figure 2017 Global Prostate Cancer Drugs Capacity Market Share by Region
Table Global Prostate Cancer Drugs Production by Region (2013-2018)
Figure Global Prostate Cancer Drugs Production (K Pcs) by Region (2013-2018)
Figure Global Prostate Cancer Drugs Production Market Share by Region (2013-2018)
Figure 2017 Global Prostate Cancer Drugs Production Market Share by Region
Table Global Prostate Cancer Drugs Revenue (Million USD) by Region (2013-2018)
Table Global Prostate Cancer Drugs Revenue Market Share by Region (2013-2018)
Figure Global Prostate Cancer Drugs Revenue Market Share by Region (2013-2018)
Table 2017 Global Prostate Cancer Drugs Revenue Market Share by Region
Figure Global Prostate Cancer Drugs Capacity, Production (K Pcs) and Growth Rate (2013-2018)
Table Global Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table North America Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Europe Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Global Prostate Cancer Drugs Consumption (K Pcs) Market by Region (2013-2018)
Table Global Prostate Cancer Drugs Consumption Market Share by Region (2013-2018)
Figure Global Prostate Cancer Drugs Consumption Market Share by Region (2013-2018)
Figure 2017 Global Prostate Cancer Drugs Consumption (K Pcs) Market Share by Region
Table North America Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Europe Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table China Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Japan Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Southeast Asia Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table India Prostate Cancer Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Global Prostate Cancer Drugs Production (K Pcs) by Type (2013-2018)
Table Global Prostate Cancer Drugs Production Share by Type (2013-2018)
Figure Production Market Share of Prostate Cancer Drugs by Type (2013-2018)
Figure 2017 Production Market Share of Prostate Cancer Drugs by Type
Table Global Prostate Cancer Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Prostate Cancer Drugs Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Prostate Cancer Drugs by Type (2013-2018)
Figure 2017 Revenue Market Share of Prostate Cancer Drugs by Type
Table Global Prostate Cancer Drugs Price (USD/Pcs) by Type (2013-2018)
Figure Global Prostate Cancer Drugs Production Growth by Type (2013-2018)
Table Global Prostate Cancer Drugs Consumption (K Pcs) by Application (2013-2018)
Table Global Prostate Cancer Drugs Consumption Market Share by Application (2013-2018)
Figure Global Prostate Cancer Drugs Consumption Market Share by Applications (2013-2018)
Figure Global Prostate Cancer Drugs Consumption Market Share by Application in 2017
Table Global Prostate Cancer Drugs Consumption Growth Rate by Application (2013-2018)
Figure Global Prostate Cancer Drugs Consumption Growth Rate by Application (2013-2018)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (AbbVie) and Gross Margin (2013-2018)
Figure AbbVie Prostate Cancer Drugs Production Growth Rate (2013-2018)
Figure AbbVie Prostate Cancer Drugs Production Market Share (2013-2018)
Figure AbbVie Prostate Cancer Drugs Revenue Market Share (2013-2018)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astellas Pharma Prostate Cancer Drugs Production Growth Rate (2013-2018)
Figure Astellas Pharma Prostate Cancer Drugs Production Market Share (2013-2018)
Figure Astellas Pharma Prostate Cancer Drugs Revenue Market Share (2013-2018)
Table Astra Zeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astra Zeneca Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astra Zeneca Prostate Cancer Drugs Production Growth Rate (2013-2018)
Figure Astra Zeneca Prostate Cancer Drugs Production Market Share (2013-2018)
Figure Astra Zeneca Prostate Cancer Drugs Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Johnson & Johnson Prostate Cancer Drugs Production Growth Rate (2013-2018)
Figure Johnson & Johnson Prostate Cancer Drugs Production Market Share (2013-2018)
Figure Johnson & Johnson Prostate Cancer Drugs Revenue Market Share (2013-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sanofi Prostate Cancer Drugs Production Growth Rate (2013-2018)
Figure Sanofi Prostate Cancer Drugs Production Market Share (2013-2018)
Figure Sanofi Prostate Cancer Drugs Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Prostate Cancer Drugs Production Growth Rate (2013-2018)
Figure GlaxoSmithKline Prostate Cancer Drugs Production Market Share (2013-2018)
Figure GlaxoSmithKline Prostate Cancer Drugs Revenue Market Share (2013-2018)
Table Merck Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Group Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck Group Prostate Cancer Drugs Production Growth Rate (2013-2018)
Figure Merck Group Prostate Cancer Drugs Production Market Share (2013-2018)
Figure Merck Group Prostate Cancer Drugs Revenue Market Share (2013-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis Prostate Cancer Drugs Production Growth Rate (2013-2018)
Figure Novartis Prostate Cancer Drugs Production Market Share (2013-2018)
Figure Novartis Prostate Cancer Drugs Revenue Market Share (2013-2018)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Amgen Prostate Cancer Drugs Production Growth Rate (2013-2018)
Figure Amgen Prostate Cancer Drugs Production Market Share (2013-2018)
Figure Amgen Prostate Cancer Drugs Revenue Market Share (2013-2018)
Table Bayer HealthCare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Prostate Cancer Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer HealthCare Prostate Cancer Drugs Production Growth Rate (2013-2018)
Figure Bayer HealthCare Prostate Cancer Drugs Production Market Share (2013-2018)
Figure Bayer HealthCare Prostate Cancer Drugs Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2017
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure Global Prostate Cancer Drugs Capacity, Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Prostate Cancer Drugs Price (Million USD) and Trend Forecast (2018-2025)
Table Global Prostate Cancer Drugs Production (K Pcs) Forecast by Region (2018-2025)
Figure Global Prostate Cancer Drugs Production Market Share Forecast by Region (2018-2025)
Table Global Prostate Cancer Drugs Consumption (K Pcs) Forecast by Region (2018-2025)
Figure Global Prostate Cancer Drugs Consumption Market Share Forecast by Region (2018-2025)
Figure North America Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure North America Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Europe Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure China Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Japan Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Southeast Asia Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure India Prostate Cancer Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Prostate Cancer Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Table Global Prostate Cancer Drugs Production (K Pcs) Forecast by Type (2018-2025)
Figure Global Prostate Cancer Drugs Production (K Pcs) Forecast by Type (2018-2025)
Table Global Prostate Cancer Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Prostate Cancer Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Prostate Cancer Drugs Price Forecast by Type (2018-2025)
Table Global Prostate Cancer Drugs Consumption (K Pcs) Forecast by Application (2018-2025)
Figure Global Prostate Cancer Drugs Consumption (K Pcs) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • Global Cytotoxic Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Jul-2018        Price: US 3480 Onwards        Pages: 136
    Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably. Scope of th......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cytotoxic Drug Market 2018, Forecast to 2023
    Published: 17-Jul-2018        Price: US 4880 Onwards        Pages: 132
    Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably. Scope of th......
  • Global Lentinan Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Jul-2018        Price: US 3480 Onwards        Pages: 133
    Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. Scope of the Report: This report focuses on the Lentinan in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. As an intravenous biological response modifier, l......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Lentinan Market 2018, Forecast to 2023
    Published: 16-Jul-2018        Price: US 4880 Onwards        Pages: 129
    Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. Scope of the Report: This report focuses on the Lentinan in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. As an intravenous biological response modifier, l......
  • Global and United States Oncology Drugs Market Research by Company, Type & Application 2013-2025
    Published: 13-Jul-2018        Price: US 2000 Onwards        Pages: 122
    Summary Market Segment as follows: By Type - Oral Therapy - Injectable Therapy By Application - Targeted Therapy - Chemotherapy - Hormonal Therapy - Biologic Therapy By Company - Novartis A.G - Laboratrio Cristlia - Medley Genomics - F. Hoffmann-La Roche Ltd - Icon Plc. - Sanofi S.A. - Laboratoires Pierre Fabre - Eurofarma Laboratrios S.A. - Ach Laboratrios Farmacu......
  • Global and United States Rhabdomyosarcoma Drug Market Research by Company, Type & Application 2013-2025
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 152
    Summary Market Segment as follows: By Type ARI-4175 Celyvir Crizotinib Enoblituzumab AT-69 Axitinib Others By Application Research Center Hospital Clinic Others By Company Bellicum Pharmaceuticals Inc Boehringer Ingelheim GmbH Bristol-Myers Squibb Co Celgene Corp Eisai Co Ltd Epizyme Inc Exelixi......
  • Global and United States Hydroxycarbamide Market Research by Company, Type & Application 2013-2025
    Published: 08-Jul-2018        Price: US 2000 Onwards        Pages: 119
    Summary Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Market Segment as follows: By Type - Capsule - Tablet By Application - Sickle Cell Disease - Cancer - Others By Company - Taj Pharma - Bristol......
  • 2018-2023 Global Lentinan Consumption Market Report
    Published: 05-Jul-2018        Price: US 4660 Onwards        Pages: 137
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Lentinan market for 2018-2023. Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. As an intravenous biological response modifier, lentinan features potent antitumor effects, remarkably prolonged life, improved life quality and mild side ef......
  • 2018 Top 5 Lentinan Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 05-Jul-2018        Price: US 4960 Onwards        Pages: 127
    Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. As an intravenous biological response modifier, lentinan features potent antitumor effects, remarkably prolonged life, improved life quality and mild side effects. First developed by Japan, lentinan was approved to enter China in 1988. Although the practical use has confirmed lentinan's efficacy, its market size has been limite......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs